In Silico Molecular Docking Analysis of Diclofenac as an Inhibitor of Succinate Dehydrogenase (SDH)

Authors

  • P. Rohini

DOI:

https://doi.org/10.52783/jns.v14.1625

Keywords:

Diclofenac, Succinate Dehydrogenase (SDH), Molecular Docking, Enzyme Inhibition, Metabolic Disorders, In Silico Analysis

Abstract

Succinate Dehydrogenase (SDH) plays a crucial role in cellular energy metabolism and redox signaling, making it a significant target for metabolic studies. This study aimed to investigate the inhibitory potential of Diclofenac on SDH using in silico molecular docking analysis. The crystal structure of human SDH (PDB ID: 6VAX) was retrieved and prepared by removing water molecules, adding hydrogen atoms, and assigning Kollman and Gasteiger charges using AutoDock. Diclofenac's 3D structure was retrieved from PubChem, optimized using OpenBabel, and prepared for docking by adjusting torsion angles and charges. Blind docking simulations were conducted to explore potential binding sites across the SDH structure using AutoDock with default parameters. The results revealed significant binding affinity between Diclofenac and SDH, with a binding energy of -8.18 kcal/mol. A hydrogen bond was observed with LYS498, while hydrophobic interactions with key residues, including ASN495, GLN569, and TYR543, contributed to the stability and specificity of the Diclofenac-SDH complex. These interactions demonstrated Diclofenac’s potential to inhibit SDH function by stabilizing within the enzyme’s active site. This study confirms Diclofenac’s inhibitory activity on SDH through molecular docking, aligning with prior in vivo evidence of its metabolic impact. The findings provide valuable insights into the molecular mechanism of SDH inhibition and its potential implications for metabolic disorders.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

AutoDock. (n.d.). AutoDock: Molecular modeling simulation software. Retrieved from https://autodock.scripps.edu

Kumar, A., Sharma, P., & Singh, R. (2019). "Role of Pi-Pi and alkyl interactions in stabilizing enzyme-inhibitor complexes: A docking and simulation study." Computational Biology and Chemistry, 78, 112-122.

Liu, X., Wang, Y., Zhang, H., & Sun, Z. (2022). Molecular docking: A critical tool in drug design and discovery. Computational Biology and Chemistry, 96, 107586.

Liu, Y., Chen, H., & Zhang, X. (2022). "In silico approaches to study enzyme inhibitors: Molecular docking and its applications." Journal of Molecular Structure, 1245, 131045.

Meng, J., Zhao, L., & Wang, Z. (2023). "Molecular docking as a tool for exploring ligand-enzyme interactions in drug discovery." Current Medicinal Chemistry, 30(4), 525-540.

Meng, X., Wang, L., Liu, F., & Zhao, Y. (2023). Advancements in molecular docking methodologies for structure-based drug design. Journal of Molecular Modeling, 29(3), 75.

OpenBabel. (n.d.). OpenBabel: The Open Source Chemistry Toolbox. Retrieved from http://openbabel.org

Pant, K., Mishra, P., & Tripathi, M. (2022). Role of mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Frontiers in Neuroscience, 16, 937121.

PubChem. (n.d.). Diclofenac (CID: 30330). National Center for Biotechnology Information. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/30330

Raj, A., Gupta, S., & Mehta, K. (2020). "NSAID interactions with metabolic enzymes: A computational and experimental approach." Biochemical Pharmacology, 178, 113931.

RCSB Protein Data Bank. (n.d.). 6VAX: Crystal structure of human Succinate Dehydrogenase. RCSB PDB. Retrieved from https://www.rcsb.org/structure/6VAX

Rohini Padma, Prameela Devi Yalavarthy (2017). In vivo inhibitory effect of Diclofenac on Succinate dehydrogenase and Acetylcholinesterase enzymes in the tissues of Channa punctatus. The American Journal of Science and Medical Research. 3(4); 10-14.

Smith, T., Clark, R., & Taylor, H. (2023). "Diclofenac beyond inflammation: Exploring its metabolic and mitochondrial effects." Trends in Pharmacological Sciences, 44(3), 200-212.

Sousa, C., Pereira, T., Santos, R., & Almeida, C. (2021). The interplay of succinate dehydrogenase and reactive oxygen species in cellular metabolism. Biochemical Journal, 478(4), 875-889.

Wang, X., Liu, J., & Zhang, Y. (2021). "Molecular insights into the inhibitory mechanisms of small molecules targeting Succinate Dehydrogenase (SDH)." Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 243-255.

Downloads

Published

2025-02-07

How to Cite

1.
Rohini P. In Silico Molecular Docking Analysis of Diclofenac as an Inhibitor of Succinate Dehydrogenase (SDH). J Neonatal Surg [Internet]. 2025Feb.7 [cited 2025Oct.4];14(1S):1022-7. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/1625

Similar Articles

You may also start an advanced similarity search for this article.